2018
The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401).
Ligibel J, Barry W, Alfano C, Hershman D, Irwin M, Neuhouser M, Thomson C, Delahanty L, Frank E, Spears P, Paskett E, Hopkins J, Bernstein V, Stearns V, White J, Wadden T, Goodwin P, Carey L, Partridge A, Winer E. The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401). Journal Of Clinical Oncology 2018, 36: tps598-tps598. DOI: 10.1200/jco.2018.36.15_suppl.tps598.Peer-Reviewed Original Research
2006
The impact of an exercise intervention on body composition, fat distribution, and weight in breast cancer survivors
Ligibel J, Chen W, Keshaviah A, Adloff K, Partridge A, Salinardi T, Winer E. The impact of an exercise intervention on body composition, fat distribution, and weight in breast cancer survivors. Journal Of Clinical Oncology 2006, 24: 590-590. DOI: 10.1200/jco.2006.24.18_suppl.590.Peer-Reviewed Original ResearchExercise interventionBreast cancer survivorsStrength training sessionBody compositionExercise groupCancer survivorsFat distributionControl groupEarly-stage breast cancerAnthropometric dataSupervised strength trainingCare control groupStage breast cancerBreast cancer recurrenceLance Armstrong FoundationComplete anthropometric dataMeasurements of weightNon-significant changesTraining sessionsAdjuvant chemotherapyObese womenEntire cohortInsulin levelsBiomarker testingCancer recurrence